The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

February 2021

Volume 16 Number 14

In this edition: management of Infective endocarditis after TAVI; characterisation of embolic debris with different TAVI devices; IVUS assessment to predict or prevent coronary artery occlusion after valve-in-valve TAVI. A mini focus on antithrombotic therapy in coronary interventions: the PENDULUM registry and high bleeding risk; clopidogrel vs ticagrelor in STEMI patients from the MIRTOS study; the TALOS-AMI trial design for DAPT de-escalation. An EAPCI position statement on elective cardiovascular procedures during the COVID-19 pandemic; the DESSOLVE III OCT study; the prognostic value of thermodilution-derived coronary flow capacity in patients with stable CAD; ventricular tachycardia, revascularisation of infarct-related artery chronic occlusion and myocardial scar; and more...

Highlights from this issue

Coronary
MIRTOS study
MIRTOS study
Hamilos M, Kanakakis J, Anastasiou I, Karvounis C, Vasilikos V, Goudevenos J, Michalis L, Koutouzis M, Tsiafoutis I, Raisakis K, Stakos D, Hahalis G, Vardas P
February 19, 2021
DOI: 10.4244/EIJ-D-20-00268

Coronary interventions